SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000769993-20-000030
Filing Date
2020-01-23
Accepted
2020-01-23 10:44:15
Documents
1
Group Members
GOLDMAN SACHS & CO. LLC

Document Format Files

Seq Description Document Type Size
1 13G ACHILLION PHARMACEUTICALS 13G_AchillionPharmaceuticals.txt SC 13G 21953
  Complete submission text file 0000769993-20-000030.txt   23603
Mailing Address 200 WEST STREET NEW YORK NY 10282
Business Address 200 WEST STREET NEW YORK NY 10282 212-902-1000
GOLDMAN SACHS GROUP INC (Filed by) CIK: 0000886982 (see all company filings)

IRS No.: 134019460 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G
SIC: 6211 Security Brokers, Dealers & Flotation Companies

Mailing Address 300 GEORGE STREET NEW HAVEN CT 06511
Business Address 300 GEORGE STREET NEW HAVEN CT 06511 203-624-7000
ACHILLION PHARMACEUTICALS INC (Subject) CIK: 0001070336 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-82163 | Film No.: 20540804
SIC: 2834 Pharmaceutical Preparations